We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Global Asbestos Deaths Keep Rising

By HospiMedica staff writers
Posted on 01 Oct 2001
Despite increasingly strict exposure standards for asbestos, the number of asbestos-linked cancers will continue to grow because of the length of time required for them to develop, according to a symposium held at the 11th Annual Congress of the European Respiratory Society (ERS) in Berlin, Germany.

Occupational asbestos exposure in Western Europe, North America, Japan, and Australia peaked in the 1970s, but recent estimates indicate that 30,000 new asbestos-related cancers continue to be diagnosed there every year. More...
These include 10,000 cases of mesotheliomas and around 20,000 cases of lung cancer. Moreover, doctors believe there will be a steady rise in the frequency of asbestos-related cancers until at least 2010 or 2020, since they take many years to develop. As a result, for example, mesothelioma rates are expected to rise in France by as much as 25% every three years.

A study by researchers at Erasmus Hospital (Brussels, Belgium) showed that in a randomly chosen urban population, out of 160 autopsies performed between 1998 and 2000, pleural plaques were found in 14% of subjects and concentrations of more than 1,000 asbestos bodies per gram of dry lung tissue were found in 13% of subjects. In other words, almost one person in every seven subjects bore the scars of asbestos exposure.

The symposium participants agreed that they urgently needed to determine the best ways of dealing with this time bomb. "Should we then screen systemically for the signs of past exposure in all patients who have had contact with asbestos?” asked Paul De Vuyst, co-chairman of the symposium and chairman of the Occupational and Environmental Health Group of ERS. "This is the crux of the question, and there are no uniform satisfactory answers at present.” At the close of the meeting, De Vuyst called for the creation of a European task force responsible for centralizing data and defining what groups would benefit from early screening.




Related Links:
European Respiratory Society (ERS)

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.